ASIA

Eisai and Biogen Receive US FDA Approval for Alzheimer’s Drug and Seek Full Approval

Jan 7 (Reuters) – The U.S. Food and Drug Administration on Friday approved Alzheimer’s disease drug lecanemab, developed by Eisai Co Ltd (4523.T) and Biogen Inc (BIIB.O) for patients in the early stages of mind sickness. Eisai and Biogen said on Saturday that the Japanese drugmaker had sought full FDA approval for the drug. The …

Eisai and Biogen Receive US FDA Approval for Alzheimer’s Drug and Seek Full Approval Read More »

Exclusive: China in talks with Pfizer for generic COVID drug

HONG KONG/BEIJING, Jan 6 (Reuters) – China is in talks with Pfizer Inc for a license that will allow domestic drugmakers to manufacture and distribute a generic version of the COVID-19 antiviral drug of US company Paxlovid in China, three sources told Reuters. China’s medical products regulator – the National Medical Products Administration (NMPA) – …

Exclusive: China in talks with Pfizer for generic COVID drug Read More »

Samsung’s quarterly profit plunges to 8-year low as demand slumps

Customers spooked by sentiment, spending squeezed Lowest profit since Q3 2014 Samsung’s first-quarter profit likely to show another slump, analysts say Shares up 1.4%, outperforming the broader market SEOUL, Jan 6 (Reuters) – Samsung Electronics Co Ltd (005930.KS) said on Friday its quarterly profit fell by two-thirds to its lowest level in eight years as …

Samsung’s quarterly profit plunges to 8-year low as demand slumps Read More »

Tesla slashes Model 3 and Model Y prices in China for second time in 3 months

SHANGHAI, Jan 6 (Reuters) – Tesla (TSLA.O) slashed car prices in China on Friday for the second time in less than three months, deepening its discounts in the world’s biggest car market as competition heats up. intensifies and the demand outlook darkens. The latest cut, along with a cut in October as well as various …

Tesla slashes Model 3 and Model Y prices in China for second time in 3 months Read More »

Dell plans to phase out chips made in China by 2024 – Nikkei

Jan 5 (Reuters) – Dell Technologies Inc (DELL.N) plans to stop using chips made in China by 2024 and has asked its suppliers to reduce the amount of other Chinese-made components in its products by because of concerns about tensions between the United States and Beijing. , the Nikkei reported on Thursday. The news comes …

Dell plans to phase out chips made in China by 2024 – Nikkei Read More »

Tesla shares suffer from New Year’s hangover over demand worries and delivery issues

The stock is the first loser in the S&P 500 on the first trading day of 2023 Selloff removes $50 billion from market capitalization Tesla misses fourth-quarter vehicle delivery estimate The electric vehicle company is still the world’s most valuable automaker Jan 3 (Reuters) – Shares of Tesla Inc (TSLA.O) started 2023 with a thud, …

Tesla shares suffer from New Year’s hangover over demand worries and delivery issues Read More »

Google alleges India’s antitrust body copied parts of EU’s Android Abuse Ordinance

Antitrust rulings in India are Google’s latest setback in a key market Google wants Indian antitrust rulings overturned Indian watchdog copied parts of EU order, Google everything Google says its conduct is not anti-competitive – filing NEW DELHI, Jan 3 (Reuters) – Google has told an Indian court that the country’s antitrust investigators copied parts …

Google alleges India’s antitrust body copied parts of EU’s Android Abuse Ordinance Read More »

Dollar set to post biggest one-day gain in three months, stocks rally

Global stocks rise slightly The correlation with the dollar is softening The yen takes a breather after the recent rally LONDON, Jan 3 (Reuters) – The dollar headed for its biggest one-day rise in more than three months on Tuesday as stocks rallied in a macro week that could offer guidance on the timing and …

Dollar set to post biggest one-day gain in three months, stocks rally Read More »